Advertisement

Contraction and Relaxation Responses to fMLP in Isolated Human Coronary Arteries

  • Mitsumasa Keitoku
  • Tamotsu Takishima

Abstract

The intimal thickening commonly found in human coronary arteries involves macrophage infiltration; this may contribute to the development of local vascular tone. We investigated the effects of the leukocyte stimulant, N-formyl-L-methionyl- L-leucyl-L-phenylalanine (fMLP), on human coronary arterial tone. For isometric tension recording, isolated human coronary arterial rings were suspended in a tissue bath filled with Krebs-Ringer solution. A single dose of fMLP (10−5M) was added to rings precontracted with 10−5M phenylephrine. Tension changes in response to fMLP were expressed as percentages of maximum potassium contraction or maximum papaverine relaxation. The inhibitors used were pretreated 15min before the addition of phenylephrine. In parallel, coronary segments were histologically examined for identifying the infiltrated inflammatory cells. In most cases examined, fMLP at 10−5M produced biphasic tension changes, with rapid contraction followed by relaxation (60±9%/–52±10%). Removal of the endothelium or adventitia did not alter the responses to fMLP. The contraction phase was nearly abolished by the thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptor blocker, ONO3708 (10−6M; 0%/–72±12%), and the selective TXA2 synthetase inhibitor, DP-1904 (10−5M; 11 ±4%/–55± 11 %). Indomethacin (2 × 10−5M) inhibited both phases, but the contraction remained small (11 ± 4%). However, the selective PGI2 synthetase inhibitor tranylcypromine (10−4M) did not reduce the relaxation phase in the presence of ONO3708 (−49 ± 15%).

Keywords

Receptor Blocker Vascular Tone Relaxation Response Contraction Phase Coronary Segment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Copyright information

© Springer-Verlag Tokyo 1993

Authors and Affiliations

  • Mitsumasa Keitoku
  • Tamotsu Takishima
    • 1
  1. 1.First Department of Internal MedicineTohoku University School of MedicineSendaiJapan

Personalised recommendations